ScoutCam Granted Canadian Patent for New Endoscope Irrigation Technology
ScoutCam's Revolutionary Healthcare Technology Further Showcases Company's Environmentally Resistant & Durable Cameras
OMER, Israel, June 12, 2020 /CNW/ -- ScoutCam, a leading developer and manufacturer of customized visual solutions and supplementary technologies, today announced the approval of its endoscope irrigation patent in Canada. The patented technology, which has already been approved for patents in other jurisdictions, including the United States, European Union, and Japan, showcases the resistance and durability of ScoutCam's micro-cameras as well as the Company's ability to reduce the diameter of its devices compared with competing endoscopes/borescopes with traditional irrigation technology, further positioning ScoutCam as a leader in the medical, industrial and aeronautic/defense sectors.
The patent features ScoutCam's micro-ScoutCam, which has been integrated into medical endoscope devices in an effort to make endoscopies less invasive and thereby contributing to the evolution of the healthcare industry. The technology covered in the patent allows adding irrigation to an endoscope without the need for an additional tube dedicated for fluids. The innovative offering saves space within the tube by unifying the water with other channels within the endoscope, which allows ScoutCam to design and manufacture an endoscope with irrigation smaller in diameter than competing devices, while using the same sensors.
"The smaller the endoscope diameter, the more pathologies it can help detect and help treat," said Yaron Silberman, Chief Executive Officer of ScoutCam. "ScoutCam's patented irrigation technology not only reduces the device diameter, but also increases the ability to see in various anatomical parts and can streamline the endoscopic process."
In order to implement the patented technology, ScoutCam cameras are embedded in the space where water flows freely, further proving that the Company's cameras are waterproof and resistant to damage in various environmental conditions. This patent-protected technology has previously been used in a therapeutic endoscope that was cleared for marketing by the U.S. Food and Drug Administration.
For more information on the micro-ScoutCam as well as the company's additional developments, please visit: https://www.scoutcam.com/
ScoutCam is a leading provider of customized visual solutions for organizations across a variety of industries in the form of highly resistant micro cameras and supplementary technologies. ScoutCam devices are used across the medical, aerospace, industrial, research and defense industries. For more information please visit: https://www.scoutcam.com/.
Cautionary Note Regarding Forward Looking Statements
Information set forth in this news release contains forward-looking statements that are based on the Company's expectations, beliefs, assumptions and intentions regarding, among other things, its product-development efforts, business, financial condition, results of operations, strategies or prospects, as of the date of this news release. They are not guarantees of future performance. Forward-looking statements can be identified by the use of forward-looking words such as "believe," "expect," "intend," "plan," "may," "should" or "anticipate" or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. The Company cautions that all forward-looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to, inter alia, the economic success and effective integration of our approved patents; the spread of COVID-19, including any resultant restrictions on our business operations and/or its negative impact on our financial condition; the Company's reliance on third-party suppliers; market acceptance of our products by prospect markets and industries; the Company's ability to raise sufficient funding in order to meet the Company's business and financial goals; and certain other factors summarized in the Company's filings with the SEC. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.
Upcoming Life Sciences Events
- August 2020
- ChinaBio® Partnering Forum 2020 Digital
- Biotechgate Digital Partnering Event
- September 2020
- Basel: Pharma-Biotech Product & Company Valuation